We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Neutrophil CD64 Index Helps Diagnose Spontaneous Bacterial Peritonitis

By LabMedica International staff writers
Posted on 17 Aug 2016
Spontaneous bacterial peritonitis (SBP) is a common and serious complication in patients with ascites caused by decompensated liver cirrhosis, and most cases are caused by bacterial infections spreading to the peritoneum across the gut wall or mesenteric lymphatics.

Although a diagnostic paracentesis and appropriate ascitic fluid analysis is considered essential for all patients admitted with ascites, the procedure is associated with dangerous complications such as bleeding and infection. More...
In the emergency setting, performing ascitic fluid culture examinations is time-consuming and not always possible.

Scientists affiliated with the Capital Medical Hospital (Beijing, China) conducted a prospective study of a total of 123 patients with ascites caused by cirrhosis who fulfilled the inclusion criteria were enrolled from March 2014 to June 2015. Aspirated ascitic fluid was collected in ethylenediaminetetraacetic acid (EDTA) tubes and analyzed within three hours of aspiration. Relevant tests were performed on blood samples to assess the condition of the patients.

Blood samples were collected within six hours after paracentesis and before antibiotic therapy; they were processed within 24 hours after collection for the measurement of CD64 expression on leukocytes by FACSCalibur flow cytometry (Becton Dickinson, Franklin Lakes, NJ, USA) using a Becton Dickinson CD14/CD64 assay kit. The kit includes fluorescein isothiocyanate (FITC)-conjugated anti-CD14 and phycoerythrin (PE)-conjugated anti-CD64 antibodies. The lymphocyte, monocyte, and neutrophil populations are defined by their forward and side scatter characteristics along with surface CD14 staining.

The teams found that the neutrophil CD64 (Fcγ receptor I) index results were significantly higher in cirrhotic patients with SBP than in those without SBP. There was a positive correlation between the neutrophil CD64 index and the polymorphonuclear neutrophil (PMN) count in ascites. In the receiver operating characteristic curve (ROC) analysis, the area under the curve (AUC) was 0.894. The optimal cut-off value for the neutrophil CD64 index was 2.02. The sensitivity and specificity of the neutrophil CD64 index for cirrhotic patients with SBP were 80.49% and 93.90%, respectively. The elevated neutrophil CD64 index was down regulated by antibiotic therapy.

The authors concluded from the results of their study the neutrophil CD64 index could be used as a sensitive and specific indicator for the diagnosis of SBP in cirrhotic patients with ascites. In addition, the neutrophil CD64 index is modulated by antibiotic therapy and could be used to evaluate the effect of therapy in SBP patients. The study was published on July 4, 2016, in the journal International Journal of Infectious Diseases.

Related Links:
Capital Medical Hospital
Becton Dickinson


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.